Al-Modawat Specialized Medical Company (TADAWUL:9594)

Saudi Arabia · Delayed Price · Currency is SAR

5.00

+0.23 (4.82%)

Jul 23, 2026, 3:13 PM AST

TADAWUL:9594 Financials Overview

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	128.05	121.82	75.49	74.31	58.57	40.84
Revenue Growth	49.58%	61.38%	1.59%	26.88%	43.41%	-
Gross Profit	52.93	52.06	30.4	40.37	27.85	14.67
Operating Income	22.04	23.99	8.04	21.88	12.14	-0.48
Net Income	16.32	18.98	6.07	18.59	10.31	-2.21
Earnings Per Share	0.23	0.27	0.09	0.33	0.18	-
EPS Growth	55.31%	203.88%	-73.13%	80.28%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Medical Services	116.45	111.43	70.15	70.91	55.52
Pharmaceutical Products	5.84	5.69	4.56	3.4	3.05
Other	5.75	4.7	0.78	-	-
Total	128.05	121.82	75.49	74.31	58.57

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2.95	12.12	15.77	0.27	1.39	6.77
Total Debt	35.65	32.48	16.34	9.19	8.6	7.86
Net Cash (Debt)	-32.7	-20.37	-0.57	-8.91	-7.21	-1.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.46	-0.29	-0.01	-0.16	-0.13	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1.27	4.28	10.07	13.6	5.09	2.27
Capital Expenditures	0.93	-2.38	-18.59	-3.92	-2.77	-4.53
Free Cash Flow	-0.34	1.9	-8.52	9.68	2.32	-2.26
Free Cash Flow Growth	-	-	-	317.48%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	41.34%	42.74%	40.27%	54.33%	47.56%	35.92%
Operating Margin	17.21%	19.69%	10.65%	29.44%	20.73%	-1.17%
Pretax Margin	13.78%	16.65%	9.00%	26.17%	18.12%	-1.70%
Profit Margin	12.75%	15.58%	8.04%	25.02%	17.61%	-5.40%
FCF Margin	-0.27%	1.56%	-11.29%	13.03%	3.96%	-5.53%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.120	-	-	0.233
Dividend Per Share Growth	0%	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	21.83	17.74	66.48	-	-	-
P/FCF Ratio	-	177.04	-	-	-	-
PS Ratio	2.78	2.76	5.35	-	-	-